We measured Concanavalin A (Con A) non-binding alphafetoprotein in amniotic fluid from 21 normal pregnancies and 20 abnormal pregnancies (complicated by anencephaly, spina bifida, or exomphalos) using small Con A-sepharose chromatography columns. There was a highly significant difference between percentage non-binding alphafetoprotein levels for pregnancies with a normal outcome (mean result 32 %; range 18--47 %) and pregnancies complicated by a neural tube defect or exomphalos (mean 14%; range 7-20%). The test is therefore of potential value in cases where there is uncertainty over the interpretation of total amniotic fluid alphafetoprotein levels.
The measurement of alphafetoprotein (AFP) in amniotic fluid is now widely used as a follow-up to serum AFP screening for the detection of neural tube defects such as spina bifida and anencephaly. When a cut-off level of five standard deviations above the mean for normal pregnancies is taken, amniotic fluid AFP estimations give a false-positive rate of 0·2% but may miss 10% of open spina bifida cases.' Thus there is a need for additional diagnostic procedures which would aid the interpretation of 'borderline' amniotic fluid AFP results, for example, those cases that fall between 2· 5 and 5 standard deviations above the mean.
AFP, a glycoprotein containing approximately 4 % carbohydrate, is composed of two molecular variants which differ only in their carbohydrate content.s Affinity chromatography using Concanavalin A (Con A) will separate amniotic fluid AFP into two components: Can A non-binding AFP, which passes through the chromatography column, and a Con A binding fraction, which is retained.
The proportion of Con A non-binding AFP in fetal serum and amniotic fluid: 2-6 % of fetal serum AFP and 14-45% of amniotic fluid AFP is not bound by Con A. 3 It is postulated that the leakage of fetal serum through the exposed membranes of neural tube defect will produce a reduction in the proportion of Con A non-binding AFP in the amniotic fluid. 4 We decided to investigate the validity of this claim and to assess the potential value of the test as a supplementary procedure for the prenatal diagnosis of neural tube defects.
Method
Amniotic fluid specimens from 21 normal pregnancies and 20 pregnancies complicated by anencephaly (14 cases), spina bifida (5), or exomphalos (1) were kindly supplied by the Regional Centre, Department of Cytogenetics, Salisbury General Infirmary. Specimens had been stored at -20 oC and were kept frozen until they were analysed. The majority of samples were taken between the 16th and 18th weeks of gestation.
Affinity chromatography using Con A bound to sepharose was performed according to the method of Smith et al. 6 with certain modifications.
An aliquot (0' 2 ml) of amniotic fluid was applied onto a column of Con A-sepharose of bed volume 5 ml. This was eluted with the equilibrating buffer (Tris/HCI 50 mmol/l, pH 7'5, containing NaCI 1 mol/l, CaCI, 1mmol/l, MnCI.l mmol/l, and sodium azide 1 g/l) and after a 3 ml void fraction had been discarded a 6 ml fraction containing the Con A non-binding AFP was collected. The bound proteins were eluted from the column using the original buffer with the addition of 5 methyl glucose (0'1 mol/I).
The AFP concentration in the non-bound fraction and the total amniotic fluid AFP were measured by radioimmunoassay (kits code 1M98, The Radiochemical Centre, Amersham Amniotic fluids from pregnancies complicated by a neural tube defect showed a decrease in percentage Con A non-binding AFP with a mean of 14% and range 7-20% ( Figure) . The difference in the groups was significant at the 0·1 % level using Student's t test or the Mann-Whitney 'U' test.
There was no correlation between percentage Con A non-binding AFP and total AFP for the normal and abnormal groups. Neither was there any correlation between Con A non-binding AFP and gestational age in the normal group at the time of sampling although results at gestational ages greater than 18 weeks were sparse.
It was necessary to validate various aspects of the assay procedure: fractionation at 4°C did not increase the fraction of AFP which bound to the Con A-sepharose, and thus separations were performed at room temperature.
Repeated freezing and thawing of specimens produced no significant change in the percentage nonbinding AFP. Results for column fractions which were freeze-dried and taken up in AFP-free serum agreed closely with those from the analysis of fractions diluted 1 in 2, 1 in 3, or 1 in 4 with AFPfree plasma. Therefore protein effects on the assay were negligible over this dilution range.
It was found that column saturation occurred when amniotic fluid specimens with high AFP levels were analysed.
To overcome this problem, all high specimens were diluted with equilibration buffer to give an AFP level of approximately 10 mg/I before they were applied to the columns. Assay precision, assessed from the results of 17 specimens analysed on duplicate columns, was between 9 and 10%. Betweenbatch coefficients of variation calculated on the results for two quality control specimens in six assays were also in the region of 9 %.
Results
The mean percentage of Con A non-binding AFP in amniotic fluid samples from pregnancies with
Discussion
Our observation that Con A non-binding AFP results were independent of gestational age is in agreement with the findings of Smith et al. 3 However, Ruoslahti et al. 8 found that the capacity of the test to differentiate between normal and pathological cases tended to disappear after the 18th week. In addition, Toflager-Larsen et al." have recently demonstrated a significant decrease in Con A nonbinding AFP with gestational age in a study of 167 normal pregnancies, using an affinity immunoelectrophoretic method.
It is interesting to compare our results with those of other workers in this field! 2 8 (Table) . The ranges quoted by each author for percentage Con A non-binding AFP in normal and abnormal pregnancies vary considerably, but this might be expected due to small sample sizes. Results from our study show a wider range for pregnancies complicated by a neural tube defect, but these are from a relatively large sample of 20 cases and are comparable to the findings of Ruoslahti et al. 8 who investigated 21 patients. Our abnormal patients were all cases in which a high total amniotic fluid AFP had led to the correct diagnosis of a fetus affected by a neural tube defect or exomphalos (1 case). Further work, such as that by Brock;' needs to be done on a larger number of samples with borderline elevations of AFP.
It has been reported that the percentage nonbinding AFP is abnormal in cases of congenital nephrosis,8 Turners syndrome, osteogenesis imperfecta, and fetal death.P Included in this study was one case of exomphalos, and it was found that this condition also produces a decrease in Con A nonbinding AFP.
We conclude that Concanavalin A-sepharose affinity chromatography has the potential to be very useful as an additional test on selected cases where there is doubt over interpretation of the total AFP results. Con A non-binding AFP estimations are convenient and despite a precision of approximately 9 % the test discriminates between normal and neural-tube-defect pregnancies with very little overlap over the gestational age range that we studied.
